Immune Checkpoint Inhibition-Does It Cause Rheumatic Diseases? Mechanisms of Cancer-Associated Loss of Tolerance and Pathogenesis of Autoimmunity
- PMID: 32631606
- DOI: 10.1016/j.rdc.2020.04.003
Immune Checkpoint Inhibition-Does It Cause Rheumatic Diseases? Mechanisms of Cancer-Associated Loss of Tolerance and Pathogenesis of Autoimmunity
Abstract
Mechanisms of immune checkpoints and their role in autoimmunity are discussed in the context of immune checkpoint inhibitor (ICI) therapy for cancer. The updated clinical spectrum of immune-related adverse events (irAEs), with an in-depth discussion of rheumatic irAEs, is presented. The relationship between ICI-induced loss of self-tolerance in cancer and the implications for understanding of irAEs, rheumatic irAEs in particular, is overviewed.
Keywords: Autoimmunity; Immune checkpoint inhibitors; Immune-related adverse events; Rheumatic diseases; Tolerance.
Copyright © 2020 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure Dr. Thanarajasingam is supported by the “Catalyst” award for Advancing in Academics Program, funded by the Department of Medicine, Mayo Clinic, Rochester, MN.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
